Cortisol activation relies heavily on 11β-HSD1 and it has been suggested that the inhibition of this enzyme may provide a target for T2D and obesity treatments, acting to improve insulin sensitivity (22, 23). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.